Since 2003 Cureline has been dedicated to innovation
in human tissue research and precision medicine.
For over seventeen years Cureline Team have been developing global collaborations and protocols for obtaining, handling, processing, and analyzing human biospecimens (HBS) worldwide. We started this business then targeted medicine was in its cradle, “precision medicine” term was not yet in use, and a “biomarker assay” was an early protagonist of “companion diagnostics”. Every year our procurement network expands to new therapeutic areas and new territories: over the years we have conducted our studies in 20 countries on four continents and supported over 600 clients with 4,000+ successfully conducted projects.
Cureline HQ are in the San Francisco Bay area with the state-of-the-art laboratories and a dedicated human tissue bank. Members of Cureline management are highly motivated and well-trained life sciences experts, clinical research and medical professionals. We strive to be involved in your biomarker R&D, companion Dx, clinical research and development process not only as service providers but also as your collaborators. Our experience and knowledge allow us to understand our clients research goals and act as an ideal partner for your scientific programs.
Cureline Management TEAM
Olga Potapova, PhD
CEO and Scientific Director
Olga Potapova is an expert in biotechnology, life sciences, business development, and international alliance management. Since 2003, Dr. Potapova is leading the Cureline Group with excellence in the area of precision medicine, translational medicine research and laboratory services. Previously she worked in the fields of cancer research (NIA, NIH, USA), human molecular genetics and genomics, oncology drug R&D and translational medicine (Pfizer/SUGEN). Since 2010 Dr. Potapova is the TCGA and CPTAC (NCI, NIH, USA) Principal Investigator. She has advanced degrees in Physics and Biochemistry and has received multiple AACR/AFLAC awards, NIH and NATO fellowships.
Sr. Vice President, Finance and Operations
Ms. Talmadge has been an entrepreneur and a business manager for over 30 years. Kathleen oversees project management and the financial activities of Cureline. Prior to joining Cureline in 2005, she was instrumental in setting up and managing various companies in the high-end retail, hospitality and service maintenance industries. She brings to the Cureline team her extensive experience in finance, accounting, purchasing and contract negotiations. Kathleen holds a B.S. in Economics from Assumption College (Makati, Philippines).
Marilda Chung, MD
Dr. Marilda Chung, MD is a Board-Certified pathologist with expertise in diagnostic Surgical Pathology and more than 25 years of experience in academic, research, and community hospital settings. She completed her Residency in Anatomic Pathology at Stanford University Medical Center, where she also completed advanced fellowships in Neuropathology and Surgical Pathology. Dr. Chung held appointments as Assistant Professor and Attending Professor at the Cornell University Medical College (New York, NY), where she was actively engaged in residency and medical student teaching, and was an Attending Pathologist in Surgical Pathology as well as Co-Director of the Division of Neuropathology. She has collaborated on numerous published papers in translational and diagnostic/oncologic pathology and has served as a Consultant Pathologist for San Francisco Bay Area research institutes since 1999. Dr. Chung currently directs the Surgical Pathology services at Saint Francis Memorial Hospital (San Francisco, CA).
Olga V. Voronina, PhD
Director, International Strategic Alliances
Dr. Voronina is a co-Founder of Cureline Inc., and has an extensive experience in international biotech, pharmaceutical and academic clinical projects. Since 2001 she has led the acquisition and archiving of human tissue specimens for drug discovery and development, and successfully established the Cureline Clinical Network. Dr. Voronina has more than 25 years biopharma experience and provides leadership in Cureline's scientific research and clinical program management worldwide. Dr. Voronina's leadership in managing Cureline TCGA program resulted in co-authoring multiple TCGA publications in Nature, Cell and NEJM (2012-2016).